Medical Design Technology -
3 Nov 2016 18:02

EndoStim, Inc., announced that the first patient has been implanted with the EndoStim device in the LESS GERD trial, at the University of Southern California. The results from the trial will support EndoStim's premarket approval application to the U.S. Food and Drug Administration (FDA). The LESS GERD trial will include a minimum of 110 subjects implanted with the EndoStim device at up to 30 sites in the United States and Europe. The trial is a multicenter, randomized, double-blind, sham-control...
Share this Article